Natural killer (NK)-resistant human lung cancer cells are lysed by recombinant interleukin-2-activated NK cells
- 31 May 1987
- journal article
- Published by Elsevier BV in Cellular Immunology
- Vol. 106 (2), 215-222
- https://doi.org/10.1016/0008-8749(87)90165-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerThe New England Journal of Medicine, 1985
- In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.JCI Insight, 1985
- Natural killer activity against cultured human neural tumor and fetal brain cellsCellular Immunology, 1985
- Modulation of human natural killer cell activity by recombinant human interleukin 2Cellular Immunology, 1985
- Natural killer cells are present in the normal human lung but are functionally impotent.JCI Insight, 1984
- Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cellsThe Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Diseases of the respiratory system. Neoplasms of the lung.BMJ, 1978